Vertex Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5,085	4,570	10,369	10,504	6,795
Short-Term Investments	1,523	1,546	849.2	274.5	729.9
Cash & Short-Term Investments	6,608	6,116	11,218	10,779	7,525
Cash Growth	8.05%	-45.48%	4.08%	43.24%	13.00%
Accounts Receivable	2,053	1,609	1,563	1,442	1,137
Receivables	2,053	1,609	1,563	1,442	1,137
Inventory	1,687	1,205	738.8	460.6	353.1
Prepaid Expenses	736.2	459.2	537.6	431.6	442.1
Restricted Cash	-	-	-	-	5.1
Other Current Assets	117.1	206.5	86.1	121.9	98.6
Total Current Assets	11,201	9,596	14,144	13,235	9,561
Property, Plant & Equipment	3,083	2,585	1,453	1,456	1,424
Long-Term Investments	5,794	5,173	2,498	112.2	-
Goodwill	1,088	1,088	1,088	1,088	1,002
Other Intangible Assets	424.2	825.9	839.9	603.6	400
Long-Term Deferred Tax Assets	2,898	2,331	1,812	1,247	934.5
Long-Term Deferred Charges	66.6	62.6	58.9	40.2	-
Other Long-Term Assets	1,089	871.9	836.4	369.4	110.8
Total Assets	25,643	22,533	22,730	18,151	13,433
Accounts Payable	461.7	413	364.9	303.9	195
Accrued Expenses	2,868	2,628	2,556	2,003	1,467
Current Portion of Leases	82.8	92.3	83.7	89.4	80.2
Current Income Taxes Payable	103.1	161.1	99.5	123.3	211.3
Current Unearned Revenue	171.8	206.8	170.3	159.6	171.7
Other Current Liabilities	173.7	63.9	273.2	62.5	16.5
Total Current Liabilities	3,861	3,565	3,547	2,742	2,142
Long-Term Leases	1,953	1,657	724.7	810.3	887.2
Other Long-Term Liabilities	1,163	901.8	877.7	685.8	303.3
Total Liabilities	6,977	6,124	5,150	4,238	3,333
Common Stock	2.5	2.6	2.6	2.6	2.5
Additional Paid-In Capital	5,119	6,672	7,450	7,387	6,881
Retained Earnings	13,560	9,607	10,142	6,523	3,201
Comprehensive Income & Other	-15.9	127.8	-14.3	0.8	15.9
Total Common Equity	18,666	16,410	17,580	13,913	10,100
Shareholders' Equity	18,666	16,410	17,580	13,913	10,100
Total Liabilities & Equity	25,643	22,533	22,730	18,151	13,433
Total Debt	2,036	1,750	808.4	899.7	967.4
Net Cash (Debt)	10,284	9,474	12,908	9,991	6,558
Net Cash Growth	8.55%	-26.60%	29.19%	52.36%	14.71%
Net Cash Per Share	39.86	36.74	49.55	38.56	25.23
Filing Date Shares Outstanding	254.03	256.79	258.31	257.09	254.58
Total Common Shares Outstanding	253.99	256.94	257.7	257.01	254.48
Working Capital	7,340	6,032	10,597	10,493	7,419
Book Value Per Share	73.49	63.87	68.22	54.13	39.69
Tangible Book Value	17,154	14,496	15,653	12,221	8,698
Tangible Book Value Per Share	67.54	56.42	60.74	47.55	34.18
Land	33.1	33.1	33.1	33.1	33.1
Buildings	483.8	461.2	928.6	903.1	892.5
Machinery	1,198	1,061	911.9	788.6	701
Leasehold Improvements	1,009	737.6	474.6	410.9	363.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.